Business profile & competitive position
Teradyne, Inc. operates inside the Technology sector, specifically the Semiconductors industry, but it is not a conventional chip designer. The company is a global provider of automated test equipment (ATE) and robotics solutions. Its test systems are used to validate semiconductors, wireless products, data storage, silicon photonics, and complex electronics across consumer electronics, automotive, computing, communications, aerospace, and defense end markets. Its robotics arm supplies collaborative robotic arms and autonomous mobile robots to manufacturing, logistics, and industrial customers.
The profitability metrics paint the picture of a business with meaningful pricing power in its core niches. The trailing net margin is 27.5%, and return on equity stands at 42.0%. A net margin above one-quarter of revenue is unusually strong for a capital-equipment supplier, while an ROE in the low-forties suggests the company is generating substantial net income relative to its equity base. Those figures are consistent with a differentiated test-and-automation franchise rather than a commodity hardware vendor. That said, an ROE near 42.0% can also be amplified by leverage or aggressive capital returns, so the headline number is best read alongside the balance sheet and free-cash generation rather than as a pure moat score. Still, in an industry where customers pay premiums for accuracy, throughput, and uptime, these margins support the argument that Teradyne holds a durable position in semiconductor test.
Financial posture
At a market capitalization of $36.2 billion and a price-to-earnings ratio of 26.4, Teradyne is priced at a clear premium to the broader market, which is typical for semiconductor equipment names exposed to AI-driven capex cycles. The 27.5% net margin and 42.0% ROE show that the valuation is backed by strong current profitability, not just growth hopes. However, the beta of 1.75 signals that the stock is expected to move roughly 75% more than the overall market in either direction, making the equity structure far more volatile than the average large-cap technology name.
The current technical snapshot also highlights this tension. The share price is $231.9, while the 50-day exponential moving average sits at $318.97—a gap of roughly 27% below the intermediate-term average. The RSI of 33.9 is brushing against commonly watched oversold thresholds. These are descriptive facts, not a directional call, but they illustrate that a company with a 26.4 P/E and 42.0% ROE can still experience sharp price dislocations when the sector reprices demand expectations.
Strategic priorities & outlook
Teradyne's most recent 10-K filing lays out a strategy built on three intertwined goals: profitably growing revenue and market share through differentiated products; maintaining balanced capital allocation between organic and inorganic investments and shareholder returns via dividends and buybacks; and continuing focused investments in artificial intelligence applications and vertically integrated producer (VIP) customers, with benefits expected to extend into 2026.
One concrete near-term milestone is the formation of MultiLane Test Products, a joint venture with MultiLane aimed at the AI Data Center equipment market, which the company expects to close in the first half of 2026. Operationally, Teradyne created the Product Test division in March 2025 to group production board test, defense and aerospace, and wireless test businesses into a single reportable segment. In 2025, Semiconductor Test revenue grew considerably, driven by AI demand in networking and VIP compute, while Product Test growth was led by defense and aerospace applications.
Two concentration figures are worth keeping in mind. International sales represented 89% of consolidated revenues in 2025, and the five largest direct customers accounted for 44% of consolidated revenues. That means revenue success is tightly linked to a small set of large global buyers and their capex decisions, particularly around AI and defense.
Macro & geopolitical exposure
As a Semiconductors industry name with 89% of sales coming from outside the United States, Teradyne's macro risk checklist starts with trade policy and currency. Semiconductor test equipment is squarely inside the range of products affected by export controls, tariffs, and national-security reviews. Any shift in U.S.-China technology relations or cross-border licensing rules can alter demand from major foundries and integrated device manufacturers.
Beyond trade, the business is exposed to the capital-investment cycle of the chip industry. When semiconductor manufacturers cut capex, test-equipment orders typically fall faster than revenue because these tools are deferred until capacity plans firm up. Currency translation is another factor, given the 89% international revenue share; a stronger U.S. dollar mechanically lowers reported overseas sales and can compress margins on foreign-denominated contracts. Defense and aerospace exposure through Product Test adds exposure to government budgets and geopolitical tensions, which can be a tailwind during rearmament cycles but a target during fiscal tightening. Finally, robotics demand is tied to manufacturing automation trends, factory reshoring, and logistics investment, all of which are sensitive to industrial production data.
Recent developments
The most recent news flow has clustered around mid-November 2026. On November 16, Teradyne announced it would present at the 2026 UBS Global Technology and AI Conference, according to businesswire.com. The same day, Zacks published a head-to-head comparison of Vertiv versus Teradyne under the title "Which AI Infrastructure Stock Is the Better Buy?" and defenseworld.net reported that Eurizon Capital SGR S.p.A. had sold shares of Teradyne. On November 13, Zacks also published "Teradyne Benefits From Strong Test Demand: Can It Beat KLAC & COHU?" These headlines capture the cross-currents currently surrounding the stock: AI-infrastructure optimism, relative-valuation debates, institutional selling activity, and competitive positioning questions within the test-equipment space.
Earnings behavior & post-earnings drift
Teradyne's earnings track record is objectively strong on the headline numbers. Over the last eight reported quarters, the company has beaten estimates eight times, for a 100% beat rate, with an average earnings surprise of 14.7%. The average five-day price move after earnings across those quarters has been a 6.81% gain, which would normally suggest a bullish post-earnings drift.
But the quarter-by-quarter mechanics tell a more nuanced story. In the most recent report on October 27, 2026, Teradyne posted EPS of $2.29 against a consensus estimate of $2.09, a 9.6% beat, yet the stock fell 3.23% the next session and dropped 16.79% over the following five trading days. On July 28, 2026, a much larger 18.2% beat produced only a 0.39% dip the next day but a 25.86% rally over the following five sessions. The April 28, 2026 quarter brought a 21.3% beat and was followed by a 19.41% one-day collapse and a 6.06% five-day decline. By contrast, the February 2, 2026 report—a 30.4% beat—led to a 13.41% next-day jump and a 24.24% gain over five days.
This pattern is the central lesson for earnings-season analysis: a beat against the official consensus does not guarantee a sustained upward price drift. Sometimes the stock sells off because guidance, order commentary, or the market's real expectation was higher than the published estimate. Teradyne's next scheduled report is January 27, 2027, after the close, with a consensus EPS estimate of $2.16. The 100% beat rate and 14.7% average surprise are useful historical context, but the recent quarter-to-quarter volatility shows that the post-earnings reaction depends at least as much on forward guidance and sector momentum as on the reported number itself.
For a deeper understanding of how sell-side and institutional analysts are interpreting Teradyne's margin trajectory, capital-return policy, and AI-data-center positioning ahead of the January 27 report, readers should consult the full institutional verdict rather than relying on headline earnings data alone.
Frequently Asked Questions
What does Teradyne actually sell?
Teradyne sells automated test equipment used to inspect semiconductors, wireless devices, data-storage products, silicon photonics, and complex electronic systems. It also sells robotics solutions—collaborative robotic arms and autonomous mobile robots—for manufacturing, logistics, and industrial customers.
How reliable has Teradyne been at beating earnings estimates?
Over the last eight reported quarters, Teradyne has beaten the consensus EPS estimate every time, for a 100% beat rate, with an average earnings surprise of 14.7%.
Does Teradyne's stock always rise after it beats earnings?
No. Despite the strong beat rate and an average five-day post-earnings drift of 6.81%, several recent beats have been followed by sharp declines. For example, the October 27, 2026 report beat estimates by 9.6% but the stock fell 16.79% over the next five trading days.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-10-27 | $2.29 | $2.09 | +9.6% | -3.23% | -16.79% |
| 2026-07-28 | $2.47 | $2.09 | +18.2% | -0.39% | +25.86% |
| 2026-04-28 | $2.56 | $2.11 | +21.3% | -19.41% | -6.06% |
| 2026-02-02 | $1.8 | $1.38 | +30.4% | +13.41% | +24.24% |
| 2025-10-28 | $0.85 | $0.79 | +7.6% | - | - |
| 2025-07-29 | $0.57 | $0.542 | +5.2% | - | - |
Previous TER editions
Get the institutional verdict on TER
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the TER verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.